CKD-843

· Chong Kun Dang Pharmaceutical

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CKD-843, covering 2025-04-08 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 3 Study to Evaluate the Safety and Efficacy of CKD-843 in Male Patients With Androgenetic Alopecia [Phase 3]

See pricing